Seo Y - Search Results

1

Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group.

Bai F, Yano Y, Kim SR, Seo Y, Miki A, Saito M, Hirano H, Momose K, Minami A, Hatazawa Y, Hayakumo T, Widasari DI, Rinonce HT, Sugano M, Tani S, Yoon S, Imoto S, Azuma T, Hotta H, Hayashi Y. Bai F, et al. Among authors: seo y. Int J Mol Med. 2014 Jun;33(6):1652-6. doi: 10.3892/ijmm.2014.1706. Epub 2014 Mar 19. Int J Mol Med. 2014. PMID: 24647743

2

Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.

Seo Y, Yoon S, Hamano K, Nakaji M, Yano Y, Katayama M, Ninomiya T, Hayashi Y, Kasuga M. Seo Y, et al. Int J Mol Med. 2004 Jan;13(1):75-9. Int J Mol Med. 2004. PMID: 14654974

3

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.

Truong BX, Seo Y, Kato M, Hamano K, Ninomiya T, Katayama M, Kato H, Yano Y, Hayashi Y, Kasuga M. Truong BX, et al. Among authors: seo y. Int J Mol Med. 2005 Aug;16(2):279-84. Int J Mol Med. 2005. PMID: 16012762 Clinical Trial.

4

Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.

Hamano K, Seo Y, Kato H, Kato M, Yano Y, Ninomiya T, Kasuga M. Hamano K, et al. Among authors: seo y. Int J Mol Med. 2006 Jun;17(6):989-95. Int J Mol Med. 2006. PMID: 16685406

5

Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.

Miki A, Yano Y, Kato H, Seo Y, Kuriyama M, Azuma T, Hayashi Y. Miki A, et al. Among authors: seo y. Int J Oncol. 2008 Mar;32(3):603-8. Int J Oncol. 2008. PMID: 18292937

6

Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy.

El-Shamy A, Shoji I, Kim SR, Ide Y, Imoto S, Deng L, Yoon S, Fujisawa T, Tani S, Yano Y, Seo Y, Azuma T, Hotta H. El-Shamy A, et al. Among authors: seo y. PLoS One. 2012;7(2):e30513. doi: 10.1371/journal.pone.0030513. Epub 2012 Feb 2. PLoS One. 2012. PMID: 22319571 Free PMC article.

7

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C.

Yano Y, Seo Y, Miki A, Saito M, Kato H, Hamano K, Oya M, Ouchi S, Fujisawa T, Yamada H, Yamashita Y, Tani S, Hirohata S, Yoon S, Kitajima N, Kitagaki K, Kawara A, Nakashima T, Yu H, Maeda T, Azuma T, El-Shamy A, Hotta H, Hayashi Y; Kobe Hepatitis Therapeutic Group. Yano Y, et al. Among authors: seo y. Int J Mol Med. 2012 Nov;30(5):1048-52. doi: 10.3892/ijmm.2012.1093. Epub 2012 Aug 9. Int J Mol Med. 2012. PMID: 22899224

8

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.

Seo Y, Yano Y. Seo Y, et al. World J Gastroenterol. 2014 Oct 7;20(37):13284-92. doi: 10.3748/wjg.v20.i37.13284. World J Gastroenterol. 2014. PMID: 25309065 Free PMC article. Review.

9

Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers.

Seo Y, Yoon S, Nakaji M, Yano Y, Nagano H, Ninomiya T, Hayashi Y, Kasuga M. Seo Y, et al. Intervirology. 2003;46(1):43-9. doi: 10.1159/000068123. Intervirology. 2003. PMID: 12566698

10

Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma.

Yano Y, Hayashi Y, Nakaji M, Nagano H, Seo Y, Ninomiya T, Yoon S, Wada A, Hirai M, Kim SR, Yokozaki H, Kasuga M. Yano Y, et al. Among authors: seo y. Int J Mol Med. 2003 Apr;11(4):499-504. Int J Mol Med. 2003. PMID: 12632104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,256 results

Search Page

Filters